BIOSCALE INC

Profile

Company Names

BIOSCALE INC

Addresses

4 MAGUIRE ROAD, LEXINGTON, MA 02421

75 SIDNEY STREET, 3RD FLOOR, CAMBRIDGE, MA 02139

Phone Numbers

781-430-6800
617-301-6000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$44,660,799.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2013-06-21 
$18,838,559.00 
$38,341,397.00 
$19,502,838.00 
Equity 
4
2013-01-25 
$1,062,028.00 
$5,097,733.00 
$4,035,705.00 
Debt 
3
2012-10-05 
$3,827,004.00 
$10,690,400.00 
$6,863,396.00 
Debt 
2
2012-02-22 
$5,261,050.00 
$10,522,100.00 
$5,261,050.00 
Debt 
1
2010-05-28 
$15,672,158.00 
$25,000,000.00 
$9,327,842.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAUL 
 
BILLINGS 
DIRECTOR
CYNTELLECT INC   |  CYNTELLECT, INC   |  BIOSCALE INC   |  CYNVENIO BIOSYSTEMS INC   |  RENNOVA HEALTH, INC.   |  BIOLOGICAL DYNAMICS INC   |  TROVAGENE, INC.   |  OMNISEQ, INC.
ISAAC 
 
CHENG 
DIRECTOR
LIQUIDIA TECHNOLOGIES INC   |  BIOSCALE INC   |  EDISON PHARMACEUTICALS INC   |  ATREAON, INC.   |  SYNCHRONEURON INC.   |  AMYLYX PHARMACEUTICALS, INC.   |  TORPEDO DIAGNOSTICS, INC.   |  DNATRIX INC   |  ADJUVANCE TECHNOLOGIES INC.   |  INCARDA THERAPEUTICS, INC.   |  MEISSA VACCINES INC   |  TALLAC THERAPEUTICS, INC.   |  APNIMED, INC.   |  MEDRHYTHMS, INC.
ISAAC 
S. 
CHENG 
DIRECTOR
BIOSCALE INC
EDWARD 
 
CRAWLEY 
DIRECTOR
DATAXU, INC.   |  BIOSCALE INC   |  EKOTROPE, INC.   |  INFINITE SKY CO
EDWARD 
F. 
CRAWLEY 
DIRECTOR
EKOTROPE, INC.   |  BIOSCALE INC
BILL 
 
DOYLE 
DIRECTOR
BIOSCALE INC   |  INVENTURE, LLC
WILLIAM 
 
DOYLE 
DIRECTOR
LINGUAFLEX, INC.   |  BIOSCALE INC   |  DOCTORS RESEARCH GROUP INC   |  AVISENA, INC   |  ANDREW TECHNOLOGIES LLC
WILLIAM 
F. 
DOYLE 
DIRECTOR
IWALK, INC.   |  WFD VENTURES FUND II, L.P.   |  OPTINOSE, INC.   |  VISIONSCOPE TECHNOLOGIES LLC   |  ASPIRE BARIATRICS, LLC   |  ASPIRE BARIATRICS, INC.   |  BIOSCALE INC   |  QUALEGEN, LLC   |  INVENTURE, LLC
BARD 
 
GEESAMAN 
DIRECTOR
BIOSCALE INC   |  MAVERICK THERAPEUTICS INC.   |  REKINDLE THERAPEUTICS INC.   |  NBO PHARMA INC.
BARD 
J. 
GEESAMAN 
DIRECTOR
CHIASMA INC   |  CHIASMA, INC   |  BIOSCALE INC   |  INFORMED MEDICAL DECISIONS, INC.
DR. MARTIN 
 
LATTERICH 
EXECUTIVE OFFICER
BIOSCALE INC
CHIP 
 
LEVEILLE 
EXECUTIVE OFFICER
BIOSCALE INC
MARK 
 
LUNDSTROM 
EXECUTIVE OFFICER, DIRECTOR
BIOSCALE INC
MARK 
E. 
LUNDSTROM 
EXECUTIVE OFFICER, DIRECTOR
BIOSCALE INC
BRETT 
 
MASTERS 
EXECUTIVE OFFICER
BIOSCALE INC
RICCARDO 
 
PIGLIUCCI 
DIRECTOR
BIOSCALE INC
SOMU 
 
SUBRAMANIAM 
DIRECTOR
BIOVEX GROUP, INC.   |  ACHRONIX SEMICONDUCTOR CORP   |  RF ARRAYS INC   |  LIGHTWIRE INC   |  RESOLVE THERAPEUTICS LLC   |  DALI SYSTEMS CO. LTD.   |  TRELLIS BIOSCIENCE LLC   |  BIOSCALE INC   |  SILICON SPACE TECHNOLOGY CORP   |  JUVENTAS THERAPEUTICS INC   |  DIRECTED SENSING INC.   |  PRIVATE GROUP NETWORKS, INC.   |  PERCEPTIMED, INC.   |  SVELTE MEDICAL SYSTEMS INC   |  ALEXAR THERAPEUTICS, INC.   |  NEW SCIENCE VENTURES FUND III, L.P.   |  NEW SCIENCE VENTURES FUND III (OFFSHORE), L.P.   |  VASCULAR THERAPIES INC   |  NSV 2016 OPPORTUNITIES FUND, L.P.   |  NSV 2016 OPPORTUNITIES FUND (OFFSHORE), L.P.   |  NSV 2017 OPPORTUNITIES FUND, L.P.   |  RALEXAR THERAPEUTICS, INC.   |  NSV 2018 NEW HORIZONS FUND, L.P.   |  NSV 2018 OPPORTUNITIES FUND, L.P.   |  NSV 2020 PREFERRED LP FUND, L.P.   |  NSV GROWTH OPPORTUNITIES FUND, L.P.   |  NSV 2021 GROWTH OPPORTUNITIES FUND, L.P.   |  PHASE FOUR, INC.   |  PAKAL TECHNOLOGIES, INC.   |  BRIGHTVOLT, INC   |  ABL SPACE SYSTEMS CO   |  GLYDWAYS, INC.   |  FERRIC, INC.
SOMU 
 
SUBRAMANIAN 
DIRECTOR
BIOSCALE INC   |  ICAD INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-07-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-21 
2013-03-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-01-25 
2013-02-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-10-05 
2012-03-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-02-22 
2010-06-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#